Zions Bancorporation’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $5.64M | Buy |
212,680
+7,374
| +4% | +$200K | 0.36% | 61 |
|
|
2024
Q3 | $5.94M | Sell |
205,306
-5,323
| -3% | -$155K | 0.43% | 42 |
|
|
2024
Q2 | $5.89M | Sell |
210,629
-7,318
| -3% | -$201K | 0.47% | 36 |
|
|
2024
Q1 | $6.05M | Buy |
217,947
+57,413
| +36% | +$1.59M | 0.45% | 38 |
|
|
2023
Q4 | $4.62M | Sell |
160,534
-12,444
| -7% | -$376K | 0.32% | 51 |
|
|
2023
Q3 | $5.74M | Buy |
172,978
+9,797
| +6% | +$346K | 0.5% | 29 |
|
|
2023
Q2 | $5.99M | Buy |
163,181
+18,516
| +13% | +$721K | 0.51% | 27 |
|
|
2023
Q1 | $5.9M | Buy |
144,665
+42,519
| +42% | +$1.84M | 0.51% | 29 |
|
|
2022
Q4 | $5.23M | Buy |
102,146
+14,666
| +17% | +$703K | 0.41% | 34 |
|
|
2022
Q3 | $3.83M | Buy |
87,480
+2,671
| +3% | +$130K | 0.4% | 38 |
|
|
2022
Q2 | $4.45M | Sell |
84,809
-7,915
| -9% | -$403K | 0.45% | 32 |
|
|
2022
Q1 | $4.8M | Buy |
92,724
+30,623
| +49% | +$1.59M | 0.43% | 29 |
|
|
2021
Q4 | $3.67M | Sell |
62,101
-14,295
| -19% | -$708K | 0.32% | 38 |
|
|
2021
Q3 | $3.29M | Sell |
76,396
-43,690
| -36% | -$1.94M | 0.34% | 38 |
|
|
2021
Q2 | $4.7M | Buy |
120,086
+25,276
| +27% | +$983K | 0.47% | 18 |
|
|
2021
Q1 | $3.44M | Buy |
94,810
+9,609
| +11% | +$341K | 0.39% | 23 |
|
|
2020
Q4 | $3.14M | Sell |
85,201
-8,134
| -9% | -$298K | 0.4% | 21 |
|
|
2020
Q3 | $3.25M | Sell |
93,335
-3,516
| -4% | -$123K | 0.46% | 18 |
|
|
2020
Q2 | $3M | Buy |
96,851
+1,999
| +2% | +$67.9K | 0.44% | 22 |
|
|
2020
Q1 | $2.94M | Buy |
94,852
+8,983
| +10% | +$306K | 0.51% | 17 |
|
|
2019
Q4 | $3.19M | Buy |
85,869
+15,808
| +23% | +$563K | 0.46% | 18 |
|
|
2019
Q3 | $2.39M | Buy |
70,061
+31,587
| +82% | +$1.15M | 0.34% | 27 |
|
|
2019
Q2 | $1.58M | Buy |
38,474
+6,790
| +21% | +$270K | 0.23% | 38 |
|
|
2019
Q1 | $1.28M | Buy |
+31,684
| New | +$1.27M | 0.21% | 51 |
|
|
2018
Q1 | – | Sell |
-76,802
| Closed | -$2.64M | – | 649 |
|
|
2017
Q4 | $2.64M | Sell |
76,802
-8,467
| -10% | -$289K | 0.45% | 26 |
|
|
2017
Q3 | $2.89M | Sell |
85,269
-6,214
| -7% | -$200K | 0.42% | 34 |
|
|
2017
Q2 | $2.92M | Buy |
91,483
+30,460
| +50% | +$961K | 0.5% | 31 |
|
|
2017
Q1 | $1.98M | Sell |
61,023
-21,620
| -26% | -$682K | 0.37% | 32 |
|
|
2016
Q4 | $2.55M | Sell |
82,643
-1,557
| -2% | -$47.5K | 0.45% | 32 |
|
|
2016
Q3 | $2.63M | Sell |
84,200
-1,449
| -2% | -$48.5K | 0.5% | 27 |
|
|
2016
Q2 | $2.92M | Sell |
85,649
-713
| -0.8% | -$22.8K | 0.51% | 24 |
|
|
2016
Q1 | $2.65M | Buy |
86,362
+4,264
| +5% | +$122K | 0.48% | 27 |
|
|
2015
Q4 | $2.3M | Buy |
82,098
+16,454
| +25% | +$518K | 0.4% | 36 |
|
|
2015
Q3 | $2.08M | Sell |
65,644
-25,976
| -28% | -$833K | 0.38% | 35 |
|
|
2015
Q2 | $2.92M | Buy |
91,620
+11,894
| +15% | +$388K | 0.47% | 33 |
|
|
2015
Q1 | $2.63M | Buy |
+79,726
| New | +$2.53M | 0.45% | 33 |
|
Other funds holding PFE
Zions Bancorporation's PFE Position: Q4 2024 in Review
Zions Bancorporation increased its Pfizer (PFE) stake by 3.6% in Q4 2024, buying an estimated $200K and bringing the position to 212,680 shares worth $5.64M. The position accounts for 0.36% of the portfolio, ranked #61.
Zions Bancorporation first reported a position in PFE in Q1 2015 and has held it in 36 quarters since. The position peaked at $6.05M in Q1 2024. 2,996 funds tracked by Wall St. Rank hold PFE as of Q4 2024.
- Zions Bancorporation held 212,680 shares of Pfizer worth $5.64M as of Q4 2024.
- Zions Bancorporation bought 7,374 Pfizer shares in Q4 2024, an estimated $200K.
- Pfizer made up 0.36% of Zions Bancorporation's portfolio in Q4 2024, its #61 holding.
- Zions Bancorporation first reported a position in Pfizer in Q1 2015 and has held it in 36 quarters since.
- Zions Bancorporation's Pfizer position peaked at $6.05M in Q1 2024.
- 2,996 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.
Based on Zions Bancorporation's 13F filing for Q4 2024, filed 11 Feb 2025.